This symposium is dedicated to exploring the rapidly evolving landscape of cellular therapies. Over two days, the symposium will engage in a comprehensive scientific program covering ground-breaking topics from the global perspective of cellular therapies to the practicalities of establishing a CAR-T program. It will delve into low- cost manufacturing models, including the Indian experience, navigate complex regulatory frameworks, and discuss the latest advances in hematopoietic cell transplantation.
The sessions will feature leading international experts discussing the role of these novel therapies in treating conditions from B-cell lymphomas and myeloma to sickle cell disease and thalassemia. The program is designed to foster collaboration and knowledge exchange among clinicians, scientists, nurses, data managers, and all healthcare professionals dedicated to advancing patient care through cellular therapy.
